Wegovy Lower Price: What UK Private Treatment Really Costs

Step 1: Understand what a legitimate Wegovy price covers

Private Wegovy prices in the UK are quoted per pen, which covers roughly four weeks of weekly injections. Since the standard titration pathway runs from 0.25mg through to 2.4mg (or, following MHRA approval in April 2026, up to the new 7.2mg maintenance dose) the pen you're on determines what you pay at any given month. A fuller breakdown of how those per-month figures move across the dose schedule is useful context before you compare providers.

Any price you see from a regulated UK supplier has to include at least the medicine and the prescription. The NHS medicines page for semaglutide explains what the treatment involves at a clinical level, which helps frame what a prescriber is actually assessing. The key point: semaglutide for weight loss is a prescription-only medicine under UK law, and no quoted price should be treated as comparable unless a genuine clinical review sits behind it.

Market pricing since Novo Nordisk adjusted UK supply has seen private monthly costs reported across a range roughly between £149 and £375, depending on dose and provider. If you want to understand what sits behind the lowest prices quoted for Wegovy and how to read those figures honestly, that context is worth reviewing before drawing conclusions. No provider should be promising you the single lowest figure across that whole range without qualification.

Step 2: Check what that headline price leaves out

A lower headline price can become a higher real cost quickly. Some providers charge separately for the consultation, the prescription, or aftercare calls. Delivery fees are common. Some platforms operate on subscription models that auto-renew before you've had a clinical re-review. The full cost picture for Wegovy covers exactly these hidden additions in more detail.

Dose-review support matters practically: titration from the starter dose upward is a clinical decision, and a prescriber who isn't reviewing your progress before each repeat is not doing their job. If a quoted price doesn't mention what happens when you need a dose change, that's worth pressing on.

It's a common assumption that a lower-priced service is simply the same service for less. In most consumer markets that's plausible. For a prescription medicine with a defined titration schedule, a Black Triangle safety designation, and ongoing MHRA monitoring, the clinical work behind the transaction is the product. Skimping on that isn't a saving.

Step 3: See what one transparent price actually includes

At nume, the price you see covers the consultation, the prescription, the treatment itself, and next-working-day DPD delivery. Nothing is billed separately, and there's no subscription running in the background. A real clinician reads your consultation (not software) and that review happens before every repeat, not just on sign-up. You can read more about how the service works on the about us page, or look at our weight-loss treatment overview for the broader picture.

We don't claim to be the cheapest option, and that's deliberate. The price reflects the pharmacy infrastructure, the independent prescribing, the aftercare, and the supply chain. Our GPhC-registered pharmacy (registration 9012878, verifiable on the GPhC register) sources Wegovy through the licensed UK supply chain. You can check any online pharmacy's registration the same way before you hand over payment details.

If you want to explore what Wegovy treatment looks like in practice (doses, the process, how titration works) the Wegovy overview page has that in full. Specific questions about pricing at individual dose steps, including how the 1mg phase fits into the cost timeline, are addressed in the 1mg price guide.

Step 4: Why the cheapest price is the wrong question for a prescription medicine

The MHRA has issued clear warnings about weight-loss medicines sold online, particularly from sources that offer them without a clinical review. Fake pens have contained the wrong active ingredient entirely. In October 2025, the MHRA raided the UK's first illicit manufacturing site producing counterfeit tirzepatide pens. This isn't a fringe risk; it's an active enforcement issue. Suspected sellers can be reported through the Yellow Card scheme, which also handles side-effect reports for patients using legitimate treatments.

NICE's appraisal of semaglutide, TA875, sets out the clinical context in which this treatment is recommended: structured support, clinical oversight, appropriate patient selection. Patients with type 2 diabetes sometimes ask how much semaglutide actually lowers blood sugar and what the clinical data shows, which is a reasonable question when weighing up the treatment as a whole. The right question isn't which provider charges the least, it's which one can demonstrate genuine prescribing, genuine supply, and genuine follow-up.

Our prescribers are available to discuss your individual situation. If you've been on Wegovy with another provider and want to transfer, or if you're starting out and unsure which treatment fits, a free consultation is the starting point. Common questions are answered on our FAQs page, and our contact page is there if you'd rather reach us directly before committing to anything.